Application 1104
Endoscopic ultrasound and fine needle aspiration for lung cancer
Endoscopic ultrasound and fine needle aspiration for lung cancer
Application No. | 1104 |
| Application Name | Endoscopic ultrasound and fine needle aspiration for lung cancer |
| Advisory Panel | Dr Kwun Fong (Chair and MSAC member) Dr Ray Kirk (MSAC member) Dr Robert Chen (co-opted member) Dr Bruce Latham (Royal Australian College of Physicians nominee) Dr Paul Mitchell (Medical Oncology Group of Australia nominee) Dr Hugh Dixson (Australian and New Zealand Physicians in Nuclear Medicine) A/Prof Louis Irving (Thoracic Society of Australia and New Zealand) A/Prof David Balls (Royal Australian and New Zealand College of Radiology nominee) Dr Gavin Michael Wright (Thoracic Society of Australia and New Zealand nominee) Ms Robin Toohey (Consumers' Health Forum of Australia nominee) |
| Date Received by MSAC Secretariat | 15 December 2005 |
| Stage 1 - Eligibility | Eligible |
| Stage 2 - Assessment | Completed |
| Stage 3 - Formulation of Advice to the Minister | MSAC has considered safety, effectiveness and cost-effectiveness for endoscopic ultrasound guided fine needle aspiration (EUS+FNA) for the staging of presumed or known non-small cell lung cancer and the diagnosis of mediastinal masses compared with current clinical practice and techniques for biopsy of mediastinal lymph nodes. MSAC finds EUS+FNA for the staging of non-small cell lung cancer when compared with current clinical practice/ techniques for biopsy of mediastinal lymph nodes and the diagnosis of mediastinal masses is as safe as current clinical practice, as effective, and cost saving. MSAC recommends that public funding is SUPPORTED for EUS+FNA for pre-treatment staging of patients with presumed or known non-small cell lung cancer and the diagnosis of mediastinal masses. |
| Stage 4 - Decision | Endorsed by the Minister for Health & Ageing on 29 August 2007 |
| Stage 5 - Implementation | Added to the MBS 1 July 2009 |
Page currency, Latest update: 03 July, 2009
